Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AskRx vs Ivy Rx

AskRx
Graded #429

Lower grade

vs+11
Ivy Rx
Graded #178

Higher grade

The verdict

Ivy Rx takes it — 66.8/100 to 55.8/100.

Ivy Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIvy Rx +38
24
62
Dose & formulationAskRx +3
67
64
Clinical oversightEven
82
82
Labs & monitoringIvy Rx +1
52
53
FulfillmentAskRx +7
88
81
Contract termsIvy Rx +35
20
55
AskRx · left barIvy Rx · right bar

The numbers

MetricAskRxIvy Rx
WeighScore55.8/10066.8/100
GradeCC
Scorecard rank#429#178
Semaglutide$349/mo (all doses, brand-name)$175/mo (starting dose, compounded)
Tirzepatide$299/mo (2.5 mg dose, brand-name)$275/mo (starting dose, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
AskRx

Graded #429 · C

Strengths

  • Prescribes only FDA-approved brand-name GLP-1s, no compounded drugs
  • LegitScript approved and HIPAA compliant
  • Board-certified physicians trained in obesity medicine
  • Transparent dose-based pricing published on site
  • Available in all 50 states

Where it loses points

  • Cash-pay model; medication cost billed separately by the pharmacy
  • Does not dispense medication itself, so fulfillment depends on third-party pharmacies
  • No compounded lower-cost alternative offered
  • Specific list of supported states is not published
Ivy Rx

Graded #178 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard